Schrezenmeier, H., Kulasekararaj, A., Mitchell, L., Sicre de Fontbrune, F., Devos, T., Okamoto, S., . . . Socié, G. (2020). One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: Open-label extension of a randomized study. Ther Adv Hematol.
Chicago Style aipamenaSchrezenmeier, Hubert, et al. "One-year Efficacy and Safety of Ravulizumab in Adults With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitor Therapy: Open-label Extension of a Randomized Study." Ther Adv Hematol 2020.
MLA aipamenaSchrezenmeier, Hubert, et al. "One-year Efficacy and Safety of Ravulizumab in Adults With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitor Therapy: Open-label Extension of a Randomized Study." Ther Adv Hematol 2020.